MyAverix Finance MyAverix Finance

LSE · Healthcare

Roquefort Investments PLC (ROQ)

Biotechnology

Roquefort Investments PLC (ROQ) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-19

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for ROQ

P/E ratio
25.00

Roquefort Investments PLC (ROQ) — FAQ

What is ROQ's P/E ratio?

The price-to-earnings (P/E) ratio for Roquefort Investments PLC (ROQ) is 25.00 (data as of 2026-05-19).

Does Roquefort Investments PLC pay a dividend?

Dividend yield is not available in the current snapshot for Roquefort Investments PLC (ROQ). Check the MyAverix Finance app for the latest dividend data.

What sector is Roquefort Investments PLC in?

Roquefort Investments PLC (ROQ) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ROQ listed on?

ROQ is listed on LSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play